The COVID-19 modified mRNA (modmRNA) lipid nanoparticle-based “vaccines” are not
classical antigen-based vaccines but instead prodrugs informed by gene therapy …

Purpose The primary aim of this work was to convert the Information System for Research in
Primary Care (SIDIAP) from Catalonia, Spain, to the Observational Medical Outcomes …

The rapid development and deployment of mRNA and non-mRNA COVID-19 vaccines have
played a pivotal role in mitigating the global pandemic. Despite their success in reducing …

Background Thrombosis associated with thrombocytopenia was a matter of concern post
first and second doses of BNT162b2 and ChAdOx1 COVID-19 vaccines. Therefore, it is …

Objective To study the association between COVID-19 vaccination and the risk of post-
COVID-19 cardiac and thromboembolic complications. Methods We conducted a staggered …

Introduction: Real-world safety studies can provide important evidence on the
thromboembolic risk associated with COVID-19 vaccines, considering that millions of people …

Thrombotic microangiopathy (TMA) associated with coronavirus disease 2019 (COVID‐19)
vaccination has been reported, however, the clinical characteristics and pathogenesis …

Recent studies elucidate that coronavirus disease 2019 (COVID‐19) patients may face a
higher risk of cardiovascular complications. This study aimed to evaluate association of …

Rationale: The 2019 coronavirus disease (COVID-19) pandemic poses a significant threat to
human health. After SARS-CoV-2 infection, major clinical concerns are organ damage and …

Importance The overall effects of vaccination on the risk of cardiac, and venous and arterial
thromboembolic complications following COVID-19 remain unclear. Objective We studied …